VYOME HOLDINGS, INC. Common Stock, Convertible, Conversion Price, Decrease
VYOME HOLDINGS, INC. (HIND) reported Common Stock, Convertible, Conversion Price, Decrease of $3.09 per share for the 1-month period ending 2026-02-28, per its 10-Q filed 2026-05-12.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockConvertibleConversionPriceDecrease · last filed 2026-05-12
- 2026-02-28: Common Stock, Convertible, Conversion Price, Decrease 1 month $3.09.
- 2025-12-31: Common Stock, Convertible, Conversion Price, Decrease 4 month $4.90.
- 2025-09-30: Common Stock, Convertible, Conversion Price, Decrease 1 month $9.00.
| Period end | Common Stock, Convertible, Conversion Price, Decrease 1 month | Common Stock, Convertible, Conversion Price, Decrease 4 month |
|---|---|---|
| 2026-02-28 | $3.09 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $4.90 10-K · filed 2026-03-18 | |
| 2025-09-30 | $9.00 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |